Actively Recruiting
Research Collaboration for a Precision Oncology Program (POP)
Led by Andreas Wicki · Updated on 2024-11-08
200
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
Sponsors
A
Andreas Wicki
Lead Sponsor
H
Hoffmann-La Roche
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Precision Oncology Program (POP) research collaboration aims to help generate information about the individual tumour biology for patients with advanced malignancies, using innovative biotechnologies and patient profile comparison ("matching") against specific databases (Real-world data, RWD) and to inform about potential benefit, or lack of benefit, from a given treatment.
CONDITIONS
Official Title
Research Collaboration for a Precision Oncology Program (POP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- For deceased persons: signed general consent
- Diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma, or similar
- ECOG performance status between 0 and 2, if applicable
- Willing and able to understand all project procedures, including sharing coded or anonymized clinical data with external partners
You will not qualify if you...
- Diagnosis of blood cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Zürich (Universitätsspital Zürich)
Zurich, Switzerland, 8091
Actively Recruiting
Research Team
A
Andreas Wicki, Professor
CONTACT
L
Laura Boos, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here